NNE was strongly involved in establishing Novo Nordisk’s insulin formulation and filling plant in Tianjin. Read about the impressive fill and finish plant.
The company’s solution was simple: Build a greenfield facility to consolidate all operations under one roof. Novozymes’ new greenfield facility in Mumbai will produce various enzymes by means of solid substrate fermentation (SSF).
PT Widatra Bhakti built a new large volume parenterals facility based on NNE’s facility design. Read about the fast-track project.
NNE challenged another company’s design for Aguettant's greenfield plant.
Read how NNE helped to bring a new greenfield API facility to life.
The 7,000 m² greenfield facility was completed in only 14½ months – from the granting of initial funding to the start of performance qualification.
NNE manages over 1,300 projects every year, from small DKK 50,000 (7,500 USD) upgrades to DKK 2 billion (300 million USD) greenfield projects.
Supporting corporate and national growth plans The greenfield project represents Boehringer Ingelheim’s first biotech venture in Asia and is part of the company’s strategy to establish production in China and penetrate the Asian biotech markets.
In my work I’m involved in everything from greenfield facilities to facilities that have undergone process optimization.
Novo Nordisk ’s new greenfield filling and inspection facility, called APX, is intended to ensure production capacity for existing and future diabetes and obesity products.